PMID- 32501499 OWN - NLM STAT- MEDLINE DCOM- 20210223 LR - 20240229 IS - 1945-7197 (Electronic) IS - 0021-972X (Print) IS - 0021-972X (Linking) VI - 105 IP - 9 DP - 2020 Sep 1 TI - An Intronic HCP5 Variant Is Associated With Age of Onset and Susceptibility to Graves Disease in UK and Polish Cohorts. PG - e3277-84 LID - dgaa347 [pii] LID - 10.1210/clinem/dgaa347 [doi] AB - CONTEXT: The genetic background of young-onset Graves disease (GD) remains largely unknown. An intronic variant in human leukocyte antigen (HLA) complex P5 (HCP5) has previously been associated with GD susceptibility and age of onset in a cohort of Polish patients. OBJECTIVE: We aimed to investigate the association of the HCP5 variant rs3094228 with GD susceptibility and age of onset in a UK cohort and conduct a meta-analysis of UK and Polish data. DESIGN AND PARTICIPANTS: rs3094228 was genotyped in 469 UK patients with GD using Taqman chemistry. Genotype frequencies were compared with genotypic data available from the Wellcome Trust case-control consortium using logistic regression analysis. To determine whether rs3094228 is independently associated with age of GD onset, the HLA DRB1*0301 tagging variant, rs535777, was also genotyped. RESULTS: The C allele of rs3094228 was overrepresented in the UK GD cohort compared with controls (P allele=5.08 x 10-9, odds ratio 1.76; [95% confidence interval, 1.46-2.13]). This association was more marked in young-onset GD (<30 years) (P allele=1.70 x 10-10 vs P allele=0.0008). The meta-analysis of UK and Polish data supported the association of the C allele with GD susceptibility (P allele=1.79 x 10-5) and age of onset (P allele=5.63 x 10-8). Haplotype analysis demonstrated that rs3094228 is associated with age of GD onset (P = 2.39 x 10-6) independent of linkage disequilibrium with HLA DRB1*0301. CONCLUSION: The rs3094228 HCP5 polymorphism is independently associated with GD susceptibility and age of onset in a UK GD cohort. Our findings indicate a potential role of long noncoding ribonucleic acids, including HCP5, in GD pathogenesis, particularly in the younger population. CI - (c) Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. FAU - Lane, Laura Claire AU - Lane LC AD - Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK. AD - Endocrine Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK. AD - Department of Paediatric Endocrinology, The Great North Children's Hospital, Newcastle-upon-Tyne, UK. FAU - Kus, Aleksander AU - Kus A AD - Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland. FAU - Bednarczuk, Tomasz AU - Bednarczuk T AD - Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland. FAU - Bossowski, Artur AU - Bossowski A AD - Department of Pediatrics, Endocrinology and Diabetes with a Cardiology Unit, Medical University of Bialystok, Bialystok, Poland. FAU - Daroszewski, Jacek AU - Daroszewski J AD - Department of Endocrinology, Diabetes and Isotope Therapy, Wroclaw Medical University, Wroclaw, Poland. FAU - Jurecka-Lubieniecka, Beata AU - Jurecka-Lubieniecka B AD - Department of Nuclear Medicine and Endocrine Oncology, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland. FAU - Cordell, Heather Jane AU - Cordell HJ AD - Population Health Sciences Institute, Newcastle University, Newcastle-upon-Tyne, UK. FAU - Pearce, Simon Henry Schofield AU - Pearce SHS AD - Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK. AD - Endocrine Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK. FAU - Cheetham, Timothy AU - Cheetham T AD - Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK. AD - Department of Paediatric Endocrinology, The Great North Children's Hospital, Newcastle-upon-Tyne, UK. FAU - Mitchell, Anna Louise AU - Mitchell AL AD - Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne, UK. AD - Endocrine Unit, Royal Victoria Infirmary, Newcastle-upon-Tyne, UK. LA - eng GR - G0500783/MRC_/Medical Research Council/United Kingdom GR - MR/S001611/1/MRC_/Medical Research Council/United Kingdom PT - Journal Article PT - Meta-Analysis PT - Research Support, Non-U.S. Gov't PL - United States TA - J Clin Endocrinol Metab JT - The Journal of clinical endocrinology and metabolism JID - 0375362 RN - 0 (HCP5 long noncoding RNA, human) RN - 0 (RNA, Long Noncoding) SB - IM MH - Adolescent MH - Adult MH - Age of Onset MH - Aged MH - Aged, 80 and over MH - Case-Control Studies MH - Child MH - Child, Preschool MH - Cohort Studies MH - Female MH - Gene Frequency MH - Genetic Association Studies MH - Genetic Predisposition to Disease MH - Graves Disease/*epidemiology/*genetics MH - Humans MH - Introns/genetics MH - Male MH - Middle Aged MH - Poland/epidemiology MH - *Polymorphism, Single Nucleotide MH - RNA, Long Noncoding/*genetics MH - United Kingdom/epidemiology MH - Young Adult PMC - PMC7382372 OTO - NOTNLM OT - Graves disease OT - autoimmune OT - genotyping OT - meta-analysis OT - polymorphism OT - thyroid EDAT- 2020/06/06 06:00 MHDA- 2021/02/24 06:00 PMCR- 2020/06/05 CRDT- 2020/06/06 06:00 PHST- 2019/12/12 00:00 [received] PHST- 2020/06/01 00:00 [accepted] PHST- 2020/06/06 06:00 [pubmed] PHST- 2021/02/24 06:00 [medline] PHST- 2020/06/06 06:00 [entrez] PHST- 2020/06/05 00:00 [pmc-release] AID - 5851730 [pii] AID - dgaa347 [pii] AID - 10.1210/clinem/dgaa347 [doi] PST - ppublish SO - J Clin Endocrinol Metab. 2020 Sep 1;105(9):e3277-84. doi: 10.1210/clinem/dgaa347.